Zelgen Biopharma Enters Strategic Partnership with AbbVie For Alveltamig
I'm PortAI, I can summarize articles.
Suzhou Zelgen Biopharmaceuticals :SAYS IT SIGNS STRATEGIC PARTNERSHIP WITH ABBVIE INC FOR DEVELOPMENT AND COMMERCIALISATION OF ALVELTAMIGSAYS TO RECEIVE $100 MILLION UPFRONT PAYMENT, ADDITIONAL $1.1 BILLION IN MILESTONE PAYMENTS IF ABBVIE EXERCISES LICENSE OPTION
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments